CT-996
CT-996 is an orally active GLP-1RA agonist, with an EC50 of 0.49 nM. CT-996 reduces the β-arrestin recruitment and GLP-1R internalization. CT-996 suppresses postprandial blood glucose following a mixed meal tolerance test (MMTT) in mice expressing the human GLP-1 receptor and enhances glucose stimulated insulin secretion (GSIS) during an intravenous glucose challenge in obese monkeys. CT-996 can be used for the study of type 2 diabetes (T2D) and obesity[1][2].
Product Specifications
CAS Number
2810808-95-6
Product Name Alternative
RO7795081; RG6652
UNSPSC
12352100
Target
Arrestin; GLP Receptor
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Purity
99.97
Solubility
DMSO : ≥ 100 mg/mL
Smiles
C[C@@H](C[C@H](CC1)OC2=NC(COC3=C(C=C(C=C3)F)F)=NC=C2)N1CC(N(C4=C5)C[C@@H]6CCO6)=NC4=CC=C5C(O)=O
Molecular Formula
C30H31F2N5O5
Molecular Weight
579.59
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Boronic acid, B-[2-chloro-4- (1,1-dimethylethyl) phenyl]-](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
Boronic acid, B-[2-chloro-4- (1,1-dimethylethyl) phenyl]-
Lentiviral mouse Mrpl58 shRNA (UAS) - Lentiviral mouse Mrpl58 shRNA (UAS, GFP) (100)
